TABLE OF CONTENTS

QUICK SEARCH:

	Author:		Keyword(s):
Year:		Vol:		Page:

Guest Access | Sign In via User Name/Password

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 108/Number 4 Supplement/October, 1995 [Index by Author]
"Fourth ACCP Consensus Conference on Antithrombotic Therapy"
Find articles in this issue containing these words: [Search ALL Issues]

Table of Contents (PDF) | Editorial Board (PDF) | Front Matter (PDF) | Back Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

ARTICLES

Introduction
James E. Dalen and Jack Hirsh Chest Oct 1995: 225S–226S. [PDF]

Clinical Recommendations Using Levels of Evidence for Antithrombotic Agents
Deborah J. Cook, Gordon H. Guyatt, Andreas Laupacis, David L. Sackett, and Robert J. Goldberg Chest Oct 1995: 227S–230S. [PDF]

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
Jack Hirsh, James E. Dalen, Daniel Deykin, Leon Poller, and Henry Bussey Chest Oct 1995: 231S–246S. [PDF]

Aspirin and Other Platelet-Active Drugs: The Relationship Among Dose, Effectiveness, and Side Effects
Jack Hirsh, James E. Dalen, Valentin Fuster, Lawrence B. Harker, Carlo Patrono, and Gerald Roth Chest Oct 1995: 247S–257S. [PDF]

Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety
Jack Hirsh, Robert Raschke, Theodore E. Warkentin, James E. Dalen, Daniel Deykin, and Leon Poller Chest Oct 1995: 258S–275S. [PDF]

Hemorrhagic Complications of Anticoagulant Treatment
Mark N. Levine, Gary Raskob, Seth Landefeld, and Jack Hirsh Chest Oct 1995: 276S–290S. [PDF]

Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism
Mark N. Levine, Samuel Z. Goldhaber, Joel M. Gore, Jack Hirsh, and Robert M. Califf Chest Oct 1995: 291S–301S. [PDF]

Therapeutic Use of n-3 Fatty Acids for Vascular Disease and Thrombosis
Scott H. Goodnight and John A. Cairns Chest Oct 1995: 302S–304S. [PDF]

Use of Antithrombotic Agents During Pregnancy
Jeffrey S. Ginsberg and Jack Hirsh Chest Oct 1995: 305S–311S. [PDF]

Prevention of Venous Thromboembolism
G. Patrick Clagett, Frederick A. Anderson, Jr, John Heit, Mark N. Levine, and H. Brownell Wheeler Chest Oct 1995: 312S–334S. [PDF]

Antithrombotic Therapy for Venous Thromboembolic Disease
Thomas M. Hyers, Russell D. Hull, and John G. Weg Chest Oct 1995: 335S–351S. [PDF]

Antithrombotic Therapy in Atrial Fibrillation
Andreas Laupacis, Gregory Albers, James Dalen, Marvin Dunn, William Feinberg, and Alan Jacobson Chest Oct 1995: 352S–359S. [PDF]

Antithrombotic Therapy in Valvular Heart Disease
Herbert J. Levine, Stephen G. Pauker, and Mark H. Eckman Chest Oct 1995: 360S–370S. [PDF]

Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
Paul D. Stein, Joseph S. Alpert, Jack Copeland, James E. Dalen, Steven Goldman, and Alexander G.G. Turpie Chest Oct 1995: 371S–379S. [PDF]

Antithrombotic Agents in Coronary Artery Disease
John A. Cairns, H. Daniel Lewis, Jr, Thomas W. Meade, George C. Sutton, and Pierre Théroux Chest Oct 1995: 380S–400S. [PDF]

Coronary Thrombolysis
John A. Cairns, Valentin Fuster, Joel Gore, and J. Ward Kennedy Chest Oct 1995: 401S–423S. [PDF]

Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts
Paul D. Stein, James E. Dalen, Steven Goldman, Leonard Schwartz, Pierre Théroux, and Alexander G.G Turpie Chest Oct 1995: 424S–430S. [PDF]

Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
G. Patrick Clagett and William C. Krupski Chest Oct 1995: 431S–443S. [PDF]

Antithrombotic Therapy for Cerebrovascular Disorders: An Update
David G. Sherman, Mark L. Dyken, Jr, Michael Gent, Michael J.G. Harrison, Robert G. Hart, and J. P. Mohr Chest Oct 1995: 444S–456S. [PDF]

Making Decisions About Antithrombotic Therapy in Heart Disease: Decision Analytic and Cost-Effectiveness Issues
Mark H. Eckman, Herbert J. Levine, and Stephen G. Pauker Chest Oct 1995: 457S–470S. [PDF]

New Antithrombotics
Jeffrey I. Weitz, Robert M. Califf, Jeffrey S. Ginsberg, Jack Hirsh, and Pierre Théroux Chest Oct 1995: 471S–485S. [PDF]

Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty
Jeffrey J. Popma, Barry S. Coller, E. Magnus Ohman, John A. Bittl, Jeffrey Weitz, Richard E. Kuntz, and Martin B. Leon Chest Oct 1995: 486S–501S. [PDF]

Medicolegal Implications of Consensus Statements
Kevin M. McIntyre Chest Oct 1995: 502S–505S. [PDF]

Antithrombotic Therapy in Children
Alan D. Michelson, Edward Bovill, and Maureen Andrew Chest Oct 1995: 506S–522S. [PDF]